TD Cowen on Twist Bioscience (TWST): 'Occam's Razor: Hitting Numbers, Closing Deals, Gaining Share + Upside Ahead'

May 5, 2025 2:43 PM EDT Send to a Friend
TD Cowen analyst Steven Mah reiterated a Buy rating and $58.00 price target on Twist Bioscience (NASDAQ: TWST)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login